Sanofi-Aventis 3Q 3Q Revenues: $8.8 billion (-1%) 3Q Earnings: $1.5 billion YTD Revenues: $26.7 billion (+3%) YTD Earnings: $4.4 billion (+100%) Comments: 3Q net sales for the pharmaceuticals business were hit hard by the introduction of generic versions of four products in the U.S. and the effect of healthcare system reforms in France and Germany, falling by 0.4% to $8.0 billion. Net sales of the top 15 products advanced by 1.5% to $5.4 billion, representing 67.5% of pharmaceutic...